The risk of infections in hematologic patients treated with rituximab is not influenced by cumulative rituximab dosage - a single center experience.

Nissen, Johanna C

The risk of infections in hematologic patients treated with rituximab is not influenced by cumulative rituximab dosage - a single center experience. [electronic resource] - BMC infectious diseases Jul 2014 - 364 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1471-2334

10.1186/1471-2334-14-364 doi


Adolescent
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Murine-Derived--administration & dosage
Antineoplastic Agents--adverse effects
Antineoplastic Combined Chemotherapy Protocols
Drug Administration Schedule
Drug Therapy, Combination
Female
Germany
Humans
Immunocompromised Host
Lymphoma, B-Cell--drug therapy
Male
Middle Aged
Prednisone--administration & dosage
Retrospective Studies
Rituximab